Helena Edlund

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Ceramide metabolism in oxidative and glycolytic muscle: Significance for lipid-induced insulin resistance.

Ceramide metabolism in oxidative and glycolytic muscle: Significance for lipid-induced insulin resistance.

Journal: Molecular metabolism

Published: December 10, 2025

Acute Hyperglycemia Induced by Hyperglycemic Clamp Affects Plasma Amyloid-β in Type 2 Diabetes.

Acute Hyperglycemia Induced by Hyperglycemic Clamp Affects Plasma Amyloid-β in Type 2 Diabetes.

Journal: Journal of Alzheimer's disease : JAD

Published: May 10, 2024

Tail Anchored protein insertion mediated by CAML and TRC40 links to neuromuscular function in mice.

Tail Anchored protein insertion mediated by CAML and TRC40 links to neuromuscular function in mice.

Journal: PLoS genetics

Published: January 30, 2024

Myofiber-specific lipidomics unveil differential contributions to insulin sensitivity in individuals of African and European ancestry.

Myofiber-specific lipidomics unveil differential contributions to insulin sensitivity in individuals of African and European ancestry.

Journal: Heliyon

Published: November 28, 2023

O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving β-cell function.

O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving β-cell function.

Journal: Communications biology

Published: October 04, 2022

Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers.

Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers.

Journal: International journal of pharmaceutics

Published: June 19, 2022

Pan-AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice.

Pan-AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice.

Journal: Scientific reports

Published: September 22, 2021

AMPK activator O304 improves metabolic and cardiac function, and exercise capacity in aged mice.

AMPK activator O304 improves metabolic and cardiac function, and exercise capacity in aged mice.

Journal: Communications biology

Published: July 26, 2021

Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP-5862, in patients with B-cell malignancies and in healthy subjects using a population pharmacokinetic approach.

Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP-5862, in patients with B-cell malignancies and in healthy subjects using a population pharmacokinetic approach.

Journal: British journal of clinical pharmacology

Published: May 27, 2021

Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignancies.

Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignancies.

Journal: British journal of clinical pharmacology

Published: February 01, 2021

α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice.

α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice.

Journal: Scientific reports

Published: August 04, 2020

PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients.

PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients.

Journal: JCI insight

Published: March 08, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026